Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time for a reverse split

Personally, I think 400MM shares is a very manageable number of shares for the company to work with.  In my mind, the goal should be to increase revenue to "match" shares, not decrease shares to accommodate current revenue.

If a reverse split was a remote possibility, such an action should be done to get on a major exchange instead of just achieving some arbitrary share count.  $5 per share could get us on the NASDAQ (provided all other requirments are met).  I'd much rather see us get there with the current share count, and I believe a combination of a win in TX and wise decision-making by Turley and company could provide the way.

BTW, thanks to all who attended the SHM and shared their notes/thoughts, from a working stiff with too little time and money to attend.

Best Regards.

Share
New Message
Please login to post a reply